Are These 3 Beaten-Down Biotech Stocks Bargains Now?
Over the past month, lots of biotech stocks have been hammered for reasons that aren't always clear. The market has made mistakes in the past and investors are right to assume it may have gone too far with some of these unfortunate companies.
Can any of these beaten-down drugmakers bounce back? Here's what investors should know before taking another step toward buying these risky stocks.
Data source: Yahoo! Finance.
Source Fool.com
